demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 outpatients
umifenovir (arbidol) Ramachandran

1 studies excluded by filtering options 3

6750 Chen_arbidol, 2020 1134not a RCThigh risk of bias